Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
anti-mesothelin CAR T cells
/
Marino Biotech
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||||||||
anti-mesothelin CAR T cells
/
Marino Biotech
New P1 trial, CAR T-Cell Therapy, Metastases:
Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors
(clinicaltrials.gov) - Oct 11, 2016
P1
, N=20, Recruiting,
Sponsor: China Meitan General Hospital